Cuprina Holdings (Cayman) Limited Class A CUPR 深 沪
等待开盘 06-26 09:30:00 美东时间
5.735
-0.005
-0.09%
华盛通- 最 高7.35
- 今 开5.16
- 成交量 34.64万股
- 最 低 3.76
- 昨 收 5.74
- 总市值 0
- 52周最高 14.80
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.22
- 委 比 91.69%
- 总股本 --
- 历史最高 14.80
- 量 比 0
- 振 幅 62.54%
- 历史最低 0.22
- 每 手 1
- 风险率 2.70%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Crude Oil Tumbles Over 5%; Empire State Manufacturing Index Falls In June
US stocks gain on peace agreement with Iran, Nasdaq up 2%, Dow up 1.1%, S&P 500 up 1.54%. Tech shares jump 2.8%, energy stocks fall 3.5%. Empire State manufacturing index drops to 5.7. Industrial production up 0.1%. Housing market index declines to 35.
06-16 00:01
Dow Jumps Over 600 Points Following US-Iran Peace Deal
US stocks rise on peace agreement with Iran, Dow up 600 points. Tech sector jumps, energy stocks down. Trump announces deal, oil futures decline.
06-15 22:08
Why Cuprina Holdings Stock Is Surging Today?
Cuprina stock jumps after regaining Nasdaq compliance, easing delisting concerns and keeping its shares listed on Nasdaq.
06-13 01:11
Cuprina Announces 1-For-8 Share Consolidation, Effective May 27
Cuprina Holdings (Cayman) Limited (NASDAQ:CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals
05-22 22:51
Cuprina Holdings Receives Nasdaq Noncompliance Notice
Cuprina Holdings (Cayman) Limited (NASDAQ:CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds, infertility, and cosmeceuticals sectors, today announced it has
2025-11-28 21:33
【华鑫新材料|深度报告】五矿资源（1208.HK）：世界级铜矿产量回升，利润有望大幅增长
（来源：华鑫研究） ▌背靠央企中国五矿集团，五矿资源主要经营铜、锌等矿产采选业务，拥有世界级大型铜矿山Las Bambas 五矿资源大股东为中国五...
2025-08-01 09:00
Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries
Singapore-based Cuprina Holdings (Cayman) Limited has set up a lab in Saudi Arabia to produce MEDIFLY maggot therapy for chronic wounds and expand its presence in the MENA region. The company also secured exclusive rights to sell medicinal leeches in GCC countries.
2025-06-04 12:00
